UCB S.A.
UCBJY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$44.28B
Close$
$117.60
21.4% downside
Current Fair Value
21.4% downsideOvervalued by 21.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $44.28 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.85 |
| Dividend yield | 0.71% |
| Earnings per Share | $3.93 |
| Beta | 0.2 |
| Outstanding Shares | 381,195,514 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 17.62 |
|---|---|
| PEG | 12.72 |
| Price to Sales | 3.74 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$2.91
Consensus analyst estimateRevenue Estimate
$4.64 B
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
$3.97
Consensus analyst estimateRevenue Estimate
$5.29 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▲ 0.00% |
|---|---|
| Total Invested | $1.88M▲ 29.02% |
| Investors Holding | 70% |
About UCB S.A.
9,000 employees
CEO: Jean-Christophe Tellier
UCB S.A., a biopharmaceutical enterprise founded in 1925 and headquartered in Brussels, Belgium, focuses on developing innovative solutions for individuals living with neurological and immunological diseases. Its diverse commercialized p...